Werewolf Therapeutics Inc.
HOWL | NASDAQ
$0.98
+$0.02 (+1.55%)
At close: Sep 21, 2026, 4:00 PM ET
$0.97
-$0.01 (-0.96%)
Pre-market:
Sep 22, 2026, 8:59 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.14M | 742K | 1.5M | 5.9M | 8.08M | 4.46M | 7.28M | 4.97M | 4.15M | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 2.45M | 398K | n/a | n/a | 406K | 426K | n/a | n/a | 454K | 464K | 460K | 445K | n/a | n/a | 13.05M | 708K | 13.89M | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 18.55M | -398K | n/a | n/a | -406K | -426K | n/a | n/a | 689K | 278K | 1.04M | 5.45M | 8.08M | 4.46M | -5.77M | 4.26M | -9.74M | n/a | n/a | n/a | n/a | n/a |
Operating Income | 8.54M | -8.97M | -9.42M | -15.73M | -17.54M | -17.99M | -20.35M | -17.12M | -18.96M | -17.16M | -12.96M | -9.25M | -6.07M | -12.22M | -13.18M | -12.54M | -14.97M | -15.37M | -17.88M | -13.8M | -10.96M | -7.45M |
Interest Income | 277K | 433K | 564K | 697K | 850K | 997K | 1.31M | 1.6M | 1.79M | 1.97M | 2.2M | 1.87M | 1.95M | 1.52M | 1.18M | 593K | 97K | 39K | 15K | 54K | 51K | 17K |
Pretax Income | 3.67M | -13.53M | -8.38M | -16.37M | -17.98M | -18.09M | -20.4M | -16.67M | -17.25M | -16.19M | -12M | -8.29M | -5.1M | -11.98M | -11.93M | -11.94M | -14.59M | -15.34M | -17.87M | -13.76M | -10.92M | -7.44M |
Net Income | 3.67M | -13.53M | -8.38M | -16.37M | -17.98M | -18.09M | -20.4M | -16.67M | -17.25M | -16.19M | -12M | -8.29M | -5.1M | -11.98M | -11.93M | -11.94M | -14.59M | -15.34M | -17.87M | -13.76M | -10.92M | -7.44M |
Selling & General & Admin | 7.68M | 5.09M | 2.49M | 4.09M | 4.4M | 4.87M | 4.62M | 4.6M | 4.38M | 4.53M | 4.35M | 4.31M | 4.57M | 4.98M | 7.41M | 3.73M | 5.23M | 4.42M | 4.48M | 4.01M | 3.69M | 2.64M |
Research & Development | 6.16M | 8.18M | 6.93M | 11.63M | 13.14M | 13.12M | 15.73M | 12.53M | 15.27M | 12.91M | 9.65M | 10.84M | 9.58M | 11.71M | 15.86M | 13.07M | 13.89M | 10.95M | 13.4M | 9.79M | 7.27M | 4.82M |
Other Expenses | -3.83M | -4.7M | n/a | n/a | -406K | -426K | n/a | n/a | n/a | n/a | n/a | -445K | n/a | n/a | -15.86M | n/a | -13.89M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 10.01M | 8.57M | 9.42M | 15.73M | 17.14M | 17.57M | 20.35M | 17.12M | 19.65M | 17.44M | 14M | 14.7M | 14.15M | 16.69M | 7.41M | 16.8M | 5.23M | 15.37M | 17.88M | 13.8M | 10.96M | 7.45M |
Interest Expense | 475K | 1.37M | 1.37M | 1.34M | 1.3M | 1.26M | 1.27M | 1.24M | 1.14M | 1M | 1.24M | 900K | 955K | 172K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -454K | -464K | -460K | n/a | n/a | n/a | 4.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.46M | 8.97M | 9.42M | 15.73M | 17.54M | 17.99M | 20.35M | 17.12M | 20.1M | 17.9M | 14.46M | 15.15M | 14.15M | 16.69M | 20.46M | 17.51M | 19.12M | 15.37M | 17.88M | 13.8M | 10.96M | 7.45M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 48.6M | 48.6M | 46.02M | 45.47M | 44.98M | 44.83M | 44.48M | 43.7M | 43.52M | 41.61M | 36.57M | 35.65M | 35.56M | 34.79M | 30.74M | 29.76M | 27.52M | 27.39M | 27.27M | 27.19M | 17.75M | 26.29M |
Shares Outstanding (Diluted) | 48.6M | 49.39M | 46.81M | 45.8M | 44.98M | 44.83M | 44.48M | 43.7M | 43.52M | 41.61M | 36.57M | 35.65M | 35.56M | 34.79M | 30.74M | 29.76M | 27.52M | 27.39M | 27.27M | 27.19M | 17.75M | 26.29M |
EPS (Basic) | 0.08 | -0.28 | -0.17 | -0.36 | -0.40 | -0.40 | -0.46 | -0.38 | -0.40 | -0.39 | -0.33 | -0.23 | -0.14 | -0.34 | -0.35 | -0.38 | -0.52 | -0.56 | -0.66 | -0.51 | -3.82 | -3.90 |
EPS (Diluted) | 0.08 | -0.28 | -0.17 | -0.36 | -0.40 | -0.40 | -0.46 | -0.38 | -0.40 | -0.39 | -0.33 | -0.23 | -0.14 | -0.34 | -0.35 | -0.38 | -0.52 | -0.56 | -0.66 | -0.51 | -3.82 | -3.90 |
EBITDA | 10.99M | -11.77M | -6.61M | -14.63M | -16.28M | -16.4M | -18.69M | -14.98M | -15.65M | -14.73M | -10.3M | -6.94M | -3.71M | -11.39M | -11.51M | -11.24M | -14.41M | -15.25M | -17.82M | -13.69M | -10.86M | -7.41M |
EBIT | 8.54M | -12.16M | -7.01M | -15.03M | -16.68M | -16.83M | -19.13M | -15.43M | -16.11M | -15.19M | -10.76M | -7.39M | -4.14M | -11.81M | -11.93M | -11.94M | -14.59M | -15.34M | -17.87M | -13.76M | -10.92M | -7.45M |
Depreciation & Amortization | 2.45M | 398K | 400K | 402K | 406K | 426K | 442K | 454K | 454K | 464K | 460K | 445K | 434K | 425K | 417K | 708K | 185K | 98K | 48K | 67K | 62K | 39K |
Add to Watchlist
Select watchlists to add or remove HOWL